Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orthofix Medical (OFIX) Cost of Revenue (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Cost of Revenue for 16 consecutive years, with $63.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 4.86% year-over-year to $63.6 million, compared with a TTM value of $256.3 million through Dec 2025, down 11.2%, and an annual FY2025 reading of $256.3 million, up 1.06% over the prior year.
  • Cost of Revenue was $63.6 million for Q4 2025 at Orthofix Medical, up from $57.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $123.9 million in Q3 2023 and bottomed at -$49.3 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $56.1 million, with a median of $62.5 million recorded in 2024.
  • The sharpest move saw Cost of Revenue crashed 191.79% in 2021, then skyrocketed 341.92% in 2024.
  • Year by year, Cost of Revenue stood at -$49.3 million in 2021, then surged by 167.04% to $33.1 million in 2022, then plummeted by 183.56% to -$27.6 million in 2023, then surged by 341.92% to $66.8 million in 2024, then decreased by 4.86% to $63.6 million in 2025.
  • Business Quant data shows Cost of Revenue for OFIX at $63.6 million in Q4 2025, $57.1 million in Q3 2025, and $63.6 million in Q2 2025.